您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Company News
Company News Brief News on Innovation
Company News
Peijia Medical Announced Proposed Share Repurchase in the Open Market
2024.06.21
Peijia Medical Announced Proposed Share ···
On June 20, Peijia Medical announced that the Board resolved to repurchase shares of the Company in ···
Peijia Medical Announced Audited 2023 Annual Results and Resumption of Trading
2024.06.17
Peijia Medical Announced Audited 2023 An···
On June 16, Peijia Medical released the announcement of its audited results for the year ended Decem···
Nearly a Hundred Investors and Analysts Attended the Peijia Medical Corporate Day, Immersing Themselves in the 'hardcore' Company Culture
2024.06.11
Nearly a Hundred Investors and Analysts ···
In late May 2024, Peijia Medical successfully held its 2024 Corporate Day and the 4th Investor Day a···
PEIJIA MEDICAL ANNOUNCED  UNAUDITED 2023 ANNUAL RESULTS
2024.03.29
PEIJIA MEDICAL ANNOUNCED UNAUDITED 2023···
On March 28, 2024, Peijia Medical announced that it would delay the publication of 2023 annual resul···
VOLUNTARY ANNOUNCEMENTUNAUDITED OPERATING STATISTICSFOR THE YEAR ENDED DECEMBER 31, 2023
2024.01.26
VOLUNTARY ANNOUNCEMENTUNAUDITED OPERATIN···
This announcement is made by Peijia Medical Limited (the “Company”, together with itssubsidiaries, t···
Peijia Medical Presented Multiple Pipeline Products at TCT 2023 Conference
2023.10.31
Peijia Medical Presented Multiple Pipeli···
Transcatheter Cardiovascular Therapeutics 2023 (TCT 2023) conference, the annual scientific symposiu···
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2023 TO JUNE 30, 2023
2023.07.24
UNAUDITED OPERATING STATISTICS FOR THE P···
UNAUDITED OPERATING STATISTICS FOR THE PERIOD FROM JANUARY 1, 2022 TO DECEMBER 31, 2022
2023.01.18
UNAUDITED OPERATING STATISTICS FOR THE P···
Peijia Medical Announced 2021 Annual Results
2022.04.06
Peijia Medical Announced 2021 Annual Res···
On March 31, 2022, Peijia Medical Limited (“Peijia Medical” or the “Company”, together with its subs···
Peijia Medical Obtained Exclusive License for JenaValve’s TrilogyTM TAVR System for Treating AR in  the Greater China Region
2022.02.07
Peijia Medical Obtained Exclusive Licens···
Peijia Medical Limited (HKEX: 9996) is pleased to announce its strategic investment and exclusive in···
Peijia Medical Announces 2021 Interim Results
2021.08.31
Peijia Medical Announces 2021 Interim Re···
Peijia Medical Announces 2021 Interim ResultsTAVR products TaurusOne® and TaurusElite® lau···
Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) P
2021.06.10
Peijia Medical Partners with inQB8 for U···
Peijia Medical (HKEX:9996, or “Peijia”), a leading player in China for medical technology, announced···
Top